First Manhattan’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-100
Closed -$1K 1386
2018
Q3
$1K Hold
100
﹤0.01% 1360
2018
Q2
$1K Hold
100
﹤0.01% 1318
2018
Q1
$0 Sell
100
-150
-60% ﹤0.01% 1401
2017
Q4
$1K Sell
250
-1,000
-80% -$4K ﹤0.01% 1408
2017
Q3
$4K Hold
1,250
﹤0.01% 1317
2017
Q2
$4K Hold
1,250
﹤0.01% 1262
2017
Q1
$5K Sell
1,250
-500
-29% -$2K ﹤0.01% 1262
2016
Q4
$4K Sell
1,750
-1,500
-46% -$3.43K ﹤0.01% 1269
2016
Q3
$10K Sell
3,250
-4,500
-58% -$13.8K ﹤0.01% 1184
2016
Q2
$13K Buy
7,750
+3,750
+94% +$6.29K ﹤0.01% 1176
2016
Q1
$7K Buy
4,000
+3,000
+300% +$5.25K ﹤0.01% 1207
2015
Q4
$3K Buy
+1,000
New +$3K ﹤0.01% 1301
2015
Q2
Sell
-1,000
Closed -$4K 1460
2015
Q1
$4K Buy
1,000
+300
+43% +$1.2K ﹤0.01% 1332
2014
Q4
$3K Buy
+700
New +$3K ﹤0.01% 1380